Tokyo Tape
Sign in
← Ono Pharmaceutical

Annual report

4528.TEDINET S100TMQ7
Period2023-04-01 → 2024-03-31
Filed2024-06-21
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥502.7bn2023-04-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥447.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥309.3bn2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥292.4bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥159.9bn2023-04-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥142.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥163.7bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥143.5bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥100.9bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥79.7bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥128.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥75.4bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥59.7bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥128.0bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥112.9bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥913.7bnat 2024-03-31Cons.Assets IFRS
Total assets¥882.4bnat 2023-03-31Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥745.4bnat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥673.4bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥115.1bnat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥134.6bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥798.6bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥747.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥793.0bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥741.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥634.1bnat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥562.5bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥166.1bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥96.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥69.0bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥110.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥159.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥74.0bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥74.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥48.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥100.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥57.6bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥10.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥89.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥24.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥54.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥266.612023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥230.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥151.112020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥118.472019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥266.572023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥230.792022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥151.092020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥118.452019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,688.43at 2024-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,519.19at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,343.4at 2022-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,270.45at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,126.95at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio86.8%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio84.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio83.5%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE16.7%2023-04-01 → 2024-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE16.1%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE12.5%2021-04-01 → 2022-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE12.6%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE10.7%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees3,853at 2024-03-31Cons.Number of employees
Employees3,761at 2023-03-31Cons.Number of employees
Employees3,687at 2022-03-31dCons.Number of employees
Employees3,607at 2021-03-31dCons.Number of employees
Employees3,560at 2020-03-31dCons.Number of employees
Revenue¥498.8bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥441.2bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥357.0bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥305.2bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥286.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥187.9bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥152.0bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥188.0bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥150.8bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥121.1bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥86.8bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥70.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥198.0bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥148.2bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥152.9bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥117.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥94.6bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥76.9bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥69.3bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥847.3bnat 2024-03-31StandaloneAssets
Total assets¥804.6bnat 2023-03-31StandaloneAssets
Total assets¥661.9bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥669.6bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥599.4bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥97.1bnat 2024-03-31StandaloneLiabilities
Total liabilities¥119.0bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥750.2bnat 2024-03-31StandaloneNet assets
Net assets / equity¥685.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥599.2bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥574.6bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥507.7bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥184.8bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥147.0bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥318.512023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥239.962022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥190.512021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥154.12020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥137.592019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥318.492023-04-01 → 2024-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥239.942022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥190.492021-04-01 → 2022-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥154.082020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥137.572019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥802023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥562021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,597.16at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,403.84at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,226.79at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,150.68at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,016.83at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio88.5%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE21.3%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE18.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE16.1%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE14.2%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE13.7%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued498,692,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued517,425,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees3,437at 2024-03-31StandaloneNumber of employees
Employees3,381at 2023-03-31StandaloneNumber of employees
Employees3,354at 2022-03-31dStandaloneNumber of employees
Employees3,319at 2021-03-31dStandaloneNumber of employees
Employees3,287at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentemployeesat 2024-03-313853 pure
Pharmaceutical Productsreportable segmentemployeesat 2024-03-313437 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,933
ItemContextValueUnit
Financial liabilities measured at amortized cost interest expenses IFRSCurrentYearDuration0JPY
Lease obligations interest expenses IFRSPrior1YearDuration73000000JPY
Lease obligations interest expenses IFRSCurrentYearDuration92000000JPY
Financial assets measured at fair value through profit or loss loss on investments in securities IFRSPrior1YearDuration46000000JPY
Financial assets measured at fair value through profit or loss loss on investments in securities IFRSCurrentYearDuration92000000JPY
Net interest on employee benefits IFRSPrior1YearDuration16000000JPY
Net interest on employee benefits IFRSCurrentYearDuration33000000JPY
Foreign exchange loss IFRSPrior1YearDuration723000000JPY
Foreign exchange loss IFRSCurrentYearDuration－JPY
Other finance costs IFRSPrior1YearDuration54000000JPY
Other finance costs IFRSCurrentYearDuration13000000JPY
Finance costs IFRSPrior1YearDuration913000000JPY
Finance costs IFRSCurrentYearDuration229000000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember147046000000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember184849000000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember108885000000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember131958000000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember20983000000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember23208000000JPY
Work in processPrior1YearInstant_NonConsolidatedMember3591000000JPY
Work in processCurrentYearInstant_NonConsolidatedMember5405000000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember18706000000JPY
Raw materials and suppliesCurrentYearInstant_NonConsolidatedMember17890000000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember3276000000JPY
Advance payments tradeCurrentYearInstant_NonConsolidatedMember1375000000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember10282000000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember14511000000JPY
Other caPrior1YearInstant_NonConsolidatedMember12263000000JPY
Other caCurrentYearInstant_NonConsolidatedMember13514000000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember325033000000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember392711000000JPY
BuildingsPrior1YearInstant_NonConsolidatedMember103181000000JPY
BuildingsCurrentYearInstant_NonConsolidatedMember103260000000JPY
Accumulated depreciation buildingsPrior1YearInstant_NonConsolidatedMember-58222000000JPY
Accumulated depreciation buildingsCurrentYearInstant_NonConsolidatedMember-60479000000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember44959000000JPY
Buildings netCurrentYearInstant_NonConsolidatedMember42781000000JPY
StructuresPrior1YearInstant_NonConsolidatedMember3701000000JPY
StructuresCurrentYearInstant_NonConsolidatedMember3666000000JPY
Accumulated depreciation structuresPrior1YearInstant_NonConsolidatedMember-2717000000JPY
Accumulated depreciation structuresCurrentYearInstant_NonConsolidatedMember-2725000000JPY
Structures netPrior1YearInstant_NonConsolidatedMember984000000JPY
Structures netCurrentYearInstant_NonConsolidatedMember940000000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember22286000000JPY
Machinery and equipmentCurrentYearInstant_NonConsolidatedMember22444000000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-16682000000JPY
Accumulated depreciation machinery and equipmentCurrentYearInstant_NonConsolidatedMember-17411000000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember5604000000JPY
Machinery and equipment netCurrentYearInstant_NonConsolidatedMember5032000000JPY
VehiclesPrior1YearInstant_NonConsolidatedMember68000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass